1. Home
  2. GRDN vs LGIH Comparison

GRDN vs LGIH Comparison

Compare GRDN & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRDN
  • LGIH
  • Stock Information
  • Founded
  • GRDN 2004
  • LGIH 2003
  • Country
  • GRDN United States
  • LGIH United States
  • Employees
  • GRDN N/A
  • LGIH N/A
  • Industry
  • GRDN Retail-Drug Stores and Proprietary Stores
  • LGIH Homebuilding
  • Sector
  • GRDN Consumer Staples
  • LGIH Consumer Discretionary
  • Exchange
  • GRDN Nasdaq
  • LGIH Nasdaq
  • Market Cap
  • GRDN 1.6B
  • LGIH 1.4B
  • IPO Year
  • GRDN 2024
  • LGIH 2013
  • Fundamental
  • Price
  • GRDN $20.50
  • LGIH $55.37
  • Analyst Decision
  • GRDN Strong Buy
  • LGIH Hold
  • Analyst Count
  • GRDN 2
  • LGIH 5
  • Target Price
  • GRDN $24.50
  • LGIH $84.00
  • AVG Volume (30 Days)
  • GRDN 267.8K
  • LGIH 376.4K
  • Earning Date
  • GRDN 08-15-2025
  • LGIH 08-05-2025
  • Dividend Yield
  • GRDN N/A
  • LGIH N/A
  • EPS Growth
  • GRDN N/A
  • LGIH N/A
  • EPS
  • GRDN N/A
  • LGIH 7.76
  • Revenue
  • GRDN $1,282,307,000.00
  • LGIH $2,163,167,000.00
  • Revenue This Year
  • GRDN $12.01
  • LGIH $1.29
  • Revenue Next Year
  • GRDN $2.33
  • LGIH $29.49
  • P/E Ratio
  • GRDN N/A
  • LGIH $7.08
  • Revenue Growth
  • GRDN 19.55
  • LGIH N/A
  • 52 Week Low
  • GRDN $14.16
  • LGIH $47.17
  • 52 Week High
  • GRDN $26.91
  • LGIH $125.83
  • Technical
  • Relative Strength Index (RSI)
  • GRDN N/A
  • LGIH 56.81
  • Support Level
  • GRDN N/A
  • LGIH $51.50
  • Resistance Level
  • GRDN N/A
  • LGIH $57.99
  • Average True Range (ATR)
  • GRDN 0.00
  • LGIH 2.78
  • MACD
  • GRDN 0.00
  • LGIH 0.68
  • Stochastic Oscillator
  • GRDN 0.00
  • LGIH 77.42

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

Share on Social Networks: